Market Tracker

08/23 3:45am ET

ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.37
Delayed Data
As of Aug 22
 +0.036 / +10.78%
Today’s Change
0.25
Today|||52-Week Range
6.32
-81.95%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.33
Today’s open0.35
Day’s range0.34 - 0.40
Volume10,244,727
Average volume (3 months)898,592
Market cap$5.3M
Dividend yield--
Data as of 3:59pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.19

Competitors

 Today’s
change
Today’s
% change
YTENYield10 Bioscience I...+0.15+6.28%
SGLBSigma Labs Inc-0.08-3.72%
OPGNOpGen Inc-0.01-4.17%
BASIBioanalytical System...-0.01-0.65%
Data as of 3:59pm ET, 08/22/2017

Financials

Last reporting dateMarch 9, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts